Alan C. Moses

6.9k citations

86 papers · 5.9k · 2 hit papers · h-index 41

Impact in

Endocrinology, Diabetes and Metabolism top 0.1%
- Growth Hormone and Insulin-like Growth Factors
- Diabetes Treatment and Management
- Diabetes Management and Research
- Thyroid Disorders and Treatments
- Pituitary Gland Disorders and Treatments
Endocrine and Autonomic Systems top 5%

Papers in

Endocrinology, Diabetes and Metabolism 59
- Growth Hormone and Insulin-like Growth Factors 37
- Diabetes Management and Research 13
- Thyroid Disorders and Treatments 9
- Diabetes Treatment and Management 8
Molecular Biology 33
- Metabolism, Diabetes, and Cancer 24
- Muscle Physiology and Disorders 4

Co-authors: S. Peter Nissley (10 shared papers)Matthew M. Rechler (10 shared papers)Jeffrey S. Flier (7 shared papers)Donatella Tramontano (4 shared papers)Sidney H. Ingbar (3 shared papers)Bernard Zinman (9 shared papers)John B. Buse (11 shared papers)David R. Clemmons (2 shared papers)
Journals: Endocrinology (16 papers)The Journal of Clinical Endocrinology & Metabolism (12 papers)Diabetes (5 papers)Diabetes Obesity and Metabolism (4 papers)European Journal of Biochemistry (3 papers)
Partner nations: United States Denmark Canada

In The Last Decade

Alan C. Moses

83 papers receiving 5.5k citations

Alan C. Moses's Hit Papers

align trajectories log scale

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes 2017 · 428 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 New England Journal of Medicine
2010 Endocrinology

Peers

Countries citing papers authored by Alan C. Moses

Since Specialization

Citations

This map shows the geographic impact of Alan C. Moses's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan C. Moses with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan C. Moses more than expected).

Fields of papers citing papers by Alan C. Moses

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan C. Moses. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan C. Moses. The network helps show where Alan C. Moses may publish in the future.

Co-authors

The 25 scholars most cited alongside Alan C. Moses, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan C. Moses Line = papers co-authored together Alan C. Moses links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation Endocrinology ·Lotte Bjerre Knudsen, Lars Wichmann Madsen, Søren Andersen, Kasper Almholt, Anne Sietske de Boer, Daniel J. Drucker, C. F. Gotfredsen, Frederikke Lihme Egerod, Anne Charlotte Hegelund, Helene Jacobsen, Søren Dyring Jacobsen, Alan C. Moses, Anne‐Marie Mølck, Henriette Svarre Nielsen, Jette Nowak, Helene Solberg, Tu D. L. Thi, Milan Zdravkovic Hit paper breakdown →	2010	537
2	Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes New England Journal of Medicine ·Steven P. Marso, Darren K. McGuire, Bernard Zinman, Neil R Poulter, Scott S. Emerson, Thomas R. Pieber, Richard E. Pratley, Poul-Martin Haahr, Martin Lange, Kirstine Brown‐Frandsen, Alan C. Moses, Simon Skibsted, Kajsa Kvist, John B. Buse Hit paper breakdown →	2017	428
3	INSULIN-LIKE GROWTH FACTOR-I STIMULATES THE GROWTH OF RAT THYROID CELLS IN CULTURE AND SYNERGIZES THE STIMULATION OF DNA SYNTHESIS INDUCED BY TSH AND GRAVES′-IgG Endocrinology ·Donatella Tramontano, Gary W. Cushing, Alan C. Moses, Sidney H. Ingbar	1986	268
4	Recombinant Human Insulin-Like Growth Factor I Increases Insulin Sensitivity and Improves Glycemic Control in Type II Diabetes Diabetes ·Alan C. Moses, Simon C. Young, Linda Morrow, Maureen E. O’Brien, David R. Clemmons	1996	254
5	Differential Cardiac Effects of Growth Hormone and Insulin-like Growth Factor1 in the Rat Circulation ·Antonio Cittadini, Hinrik Strömer, Sarah E. Katz, Ross Clark, Alan C. Moses, James P. Morgan, Pamela S. Douglas	1996	247
6	Interactions of Insulin-Like Growth Factors I and II and Multiplication-Stimulating Activity with Receptors and Serum Carrier Proteins Endocrinology ·Matthew M. Rechler, Jürgen Zapf, S. Peter Nissley, E. R. Froesch, Alan C. Moses, Judy M. Podskalny, Ellen Van Obberghen‐Schilling, R Humbel	1980	237
7	Insulin Administered Intranasally as an Insulin-Bile Salt Aerosol: Effectiveness and Reproducibility in Normal and Diabetic Subjects Diabetes ·Alan C. Moses, Gilad S. Gordon, Martin C. Carey, Jeffrey S. Flier	1983	182
8	Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial American Heart Journal ·Steven P. Marso, Neil R Poulter, Steven E. Nissen, Michael A. Nauck, Bernard Zinman, Gilbert H. Daniels, Stuart Pocock, William M. Steinberg, Richard M. Bergenstal, Johannes F.E. Mann, Lasse Steen Ravn, Kirstine Brown Frandsen, Alan C. Moses, John B. Buse	2013	177
9	GLP-1 and Calcitonin Concentration in Humans: Lack of Evidence of Calcitonin Release from Sequential Screening in over 5000 Subjects with Type 2 Diabetes or Nondiabetic Obese Subjects Treated with the Human GLP-1 Analog, Liraglutide The Journal of Clinical Endocrinology & Metabolism ·László Hegedüs, Alan C. Moses, Milan Zdravković, Tu Le Thi, Gilbert H. Daniels	2011	163
10	Purification and Characterization of Multiplication‐Stimulating Activity European Journal of Biochemistry ·Alan C. Moses, S. Peter Nissley, Patricia A. Short, Matthew M. Rechler, Judy M. Podskalny	1980	163
11	A longitudinal study of the growth of the New Zealand white rabbit: Cumulative and biweekly incremental growth rates for body length, body weight, femoral length, and tibial length Journal of Orthopaedic Research® ·Ibrahim Masoud, Frederic Shapiro, Ralph Kent, Alan C. Moses	1986	161
12	Specific binding of a somatomedin-like polypeptide in rat serum depends on growth hormone Nature ·Alan C. Moses, S. Peter Nissley, Kenneth L. Cohen, Matthew M. Rechler	1976	136
13	Insulin-like Growth Factor-1 but Not Growth Hormone Augments Mammalian Myocardial Contractility by Sensitizing the Myofilament to Ca ²⁺ Through a Wortmannin-Sensitive Pathway Circulation Research ·Antonio Cittadini, Yoshiki Ishiguro, Hinrik Strömer, Matthias Spindler, Alan C. Moses, Ross Clark, Pamela S. Douglas, Joanne S. Ingwall, James P. Morgan	1998	133
14	Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2) Diabetologia ·(unknown), Bernard Zinman, Steven P. Marso, Neil R Poulter, Scott S. Emerson, Thomas R. Pieber, Richard E. Pratley, Martin Lange, Kirstine Brown‐Frandsen, Alan C. Moses, Ann Marie Ocampo Francisco, Jesper Barner Lekdorf, Kajsa Kvist, John B. Buse	2017	132
15	Adenosine 3′,5′-Monophosphate Mediates Both the Mitogenic Effect of Thyrotropin and Its Ability to Amplify the Response to Insulin-Like Growth Factor I in FRTL5 Cells* Endocrinology ·Donatella Tramontano, Alan C. Moses, Bianca Maria Veneziani, Sidney H. Ingbar	1988	131
16	Further Characterization of Growth Hormone-Dependent Somatomedin-Binding Proteins in Rat Serum and Demonstration of Somatomedin-Binding Proteins Produced by Rat Liver Cells in Culture* Endocrinology ·Alan C. Moses, Peter Nissley, John Passamani, Robert M. White	1979	131
17	DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality Diabetologia ·(unknown), Thomas R. Pieber, Steven P. Marso, Darren K. McGuire, Bernard Zinman, Neil R Poulter, Scott S. Emerson, Richard E. Pratley, Vincent Woo, Simon Heller, Martin Lange, Kirstine Brown‐Frandsen, Alan C. Moses, Jesper Barner Lekdorf, Lucine Lehmann, Kajsa Kvist, John B. Buse	2017	115
18	The Combination of Insulin-Like Growth Factor I and Insulin-Like Growth Factor-Binding Protein-3 Reduces Insulin Requirements in Insulin-Dependent Type 1 Diabetes: Evidence forin VivoBiological Activity¹ The Journal of Clinical Endocrinology & Metabolism ·David R. Clemmons, Alan C. Moses, M J McKay, Andreas Sommer, David Rosen, (unknown)	2000	111
19	Effects of Sodium Taurodihydrofusidate on Nasal Absorption of Insulin in Sheep Journal of Pharmaceutical Sciences ·John P. Longenecker, Alan C. Moses, Jeffrey S. Flier, Robert D. Silver, Martin C. Carey, Edward J. Dubovi	1987	107
20	Circulating Insulin Concentrations, Smoking, and Alcohol Intake Are Important Independent Predictors of Leptin in Young Healthy Men Obesity Research ·Christos S. Mantzoros, Antonios Liolios, Nicholas A. Tritos, Virginia Kaklamani, D. Doulgerakis, Ioannis Griveas, Alan C. Moses, Jeffrey S. Flier	1998	102

About Alan C. Moses

Alan C. Moses is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery, Physiology and Cardiology and Cardiovascular Medicine, having authored 86 papers that have together received 5.9k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (37 papers), Metabolism, Diabetes, and Cancer (24 papers), Diabetes Management and Research (13 papers), Thyroid Disorders and Treatments (9 papers), Diabetes Treatment and Management (8 papers), Pancreatic function and diabetes (7 papers), Muscle Physiology and Disorders (4 papers) and Lipid metabolism and disorders (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.7k citations), Endocrine and Autonomic Systems (229 citations), Molecular Biology (2.1k citations), Pharmaceutical Science (157 citations) and Surgery (1.0k citations). Alan C. Moses has collaborated with scholars based in United States, Denmark and Canada. Frequent co-authors include S. Peter Nissley, Matthew M. Rechler, Jeffrey S. Flier, Donatella Tramontano, Sidney H. Ingbar, Bernard Zinman, John B. Buse, David R. Clemmons, Steven P. Marso and Gary W. Cushing. Their work appears in journals such as Endocrinology, The Journal of Clinical Endocrinology & Metabolism, Diabetes, Diabetes Obesity and Metabolism and European Journal of Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Alan C. Moses

Impact in

Papers in i

In The Last Decade

Alan C. Moses

Alan C. Moses's Hit Papers

Peers

Countries citing papers authored by Alan C. Moses

Fields of papers citing papers by Alan C. Moses

All Works

About Alan C. Moses

Explore authors with similar magnitude of impact

Papers in